0001363585-13-000016.txt : 20130620 0001363585-13-000016.hdr.sgml : 20130620 20130620160016 ACCESSION NUMBER: 0001363585-13-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130618 FILED AS OF DATE: 20130620 DATE AS OF CHANGE: 20130620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FELLOWS STEPHEN CENTRAL INDEX KEY: 0001363585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 13924500 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE STREET 2: SUITE 202 CITY: TORONTO STATE: A6 ZIP: M5J 2G2 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-06-18 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001363585 FELLOWS STEPHEN 555 RICHMOND STREET WEST, PO BOX 200 SUITE 604 TORONTO A6 M5V3B1 ONTARIO, CANADA 0 1 0 0 Chief Financial Officer Common Stock 2013-06-18 4 S 0 2524164 0.0355 D 0 D The shares sold were acquired by the reporting person on June 6, 2013 upon exercise of options to purchase 2,524,164 shares of the issuer's common stock which were granted by the Board of Directors on March 5, 2013 and June 4, 2013 in lieu of cash payment of deferred compensation. The option grants were effective upon the reporting person's execution of Settlement and Release Agreements with the issuer on April 1, 2013 and June 6, 2013, respectively. The option grants were made pursuant to the terms of the issuer's 2006 stock plan. Stephen Fellows 2013-06-20